September 19, 2017 9:04 PM ET

Pharmaceuticals

Company Overview of FUJIFILM RI Pharma Co.,Ltd.

Company Overview

FUJIFILM RI Pharma Co.,Ltd. is a nuclear medicine company that engages in the research and development, manufacture, sale, export, and import of radiopharmaceutical/non-radiopharmaceutical products and radio-labeled compounds. It offers diagnostic radiopharmaceuticals for use in various applications, such as brain imaging, thyroid function test, heart imaging, malignant tumor and adrenal imaging, bone imaging, liver imaging, kidney imaging, lung imaging, and hematological function test; therapeutic radiopharmaceuticals that are used as radioiodine for thyroid therapy and radioimmunotherapy of non-hodgkin's iymphoma; and contrast media for non-ionic X-ray contrast medium and liver function im...

14-1, kyobashi 2-Chome

Chuo-Ku

Tokyo,  104-0031

Japan

Founded in 1968

Phone:

81 3 5250 2600

Fax:

81 3 5250 2625

Key Executives for FUJIFILM RI Pharma Co.,Ltd.

Chief Executive Officer and President
Corporate Vice President and Director
Corporate Vice President
Corporate Vice President
Corporate Vice President and Director
Compensation as of Fiscal Year 2017.

FUJIFILM RI Pharma Co.,Ltd. Key Developments

Advanced Accelerator Applications and FUJIFILM RI Pharma, Co., LTD Announce First Patient in Bridging Study in Japan for Lutetium Lu 177 Dotatate (Lutathera®)

Advanced Accelerator Applications S.A. announced that the first patient has been treated in a Phase I clinical study of lutetium Lu 177 dotatate in patients with inoperable, somatostatin receptor positive, progressive pancreatic, gastrointestinal, or pulmonary neuroendocrine tumors (NETs) in Japan. The primary objective of this open-label, uncontrolled, single-center, bridging study is to evaluate the safety, tolerability, pharmacokinetics, and dosimetry of lutetium Lu 177 dotatate in Japanese patients. Six subjects will be included in the Phase I study. This is an important step forward in bringing lutetium Lu 177 dotatate (Lutathera®) to the Japanese population. Asia represents a significant opportunity to work with a strong regional partner like FUJIFILM RI Pharma that has extensive expertise in commercializing novel radiopharmaceuticals.

Similar Private Companies By Industry

Company Name Region
ABsize Inc. Asia
AccuRna, Inc. Asia
ACE Japan, L.L.C. Asia
AETAS Pharma Co.,Ltd. Asia
AIP Corporation Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact FUJIFILM RI Pharma Co.,Ltd., please visit fri.fujifilm.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.